January 2019 - INP104 met the predefined statistical criteria for comparative bioavailability with IV DHE and Migranal. The shorter time to reach Cmax and at 4 times the plasma concentration of DHE in comparison to Migranal combined with a favorable tolerability profile support further investigation of INP104 as an effective,...

August 2018 - This study, administering L-dopa to the vascular-rich upper nasal space with the novel POD device should guide further clinical development for an easy self or care-giver administered, rapidly effective treatment to abort OFF episodes in PD....